SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001683168-20-001266
Filing Date
2020-04-23
Accepted
2020-04-23 16:40:00
Documents
2
Period of Report
2020-04-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1626
2 POWER OF ATTORNEY edwards_poa.htm EX-24 6834
  Complete submission text file 0001683168-20-001266.txt   9862
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Issuer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address
Edwards Robert Grant (Reporting) CIK: 0001810327 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33216 | Film No.: 20811524